Evidence map›Paper›PMID 27867011›Full record

ArticleMolecular cell2016

Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.

Jun Fan, Ruiting Lin, Siyuan Xia, Dong Chen, Shannon E Elf, Shuangping Liu, Yaozhu Pan, Haidong Xu, Zhiyu Qian, Mei Wang and 20 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 5 institutions in 2 countries.

Jun FanDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: jfan3@emory.edu.
Ruiting LinDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Siyuan XiaDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Dong ChenDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Shannon E ElfDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Shuangping LiuDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Yaozhu PanDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Haidong XuDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Zhiyu QianDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Mei WangDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Changliang ShanDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Lu ZhouFudan University, Shanghai 201203, China.
Qun-Ying LeiFudan University, Shanghai 201203, China.
Yuancheng LiDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hui MaoDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Benjamin H LeeNovartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
Jessica SudderthChildren's Research Institute, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Ralph J DeBerardinisChildren's Research Institute, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Guojing ZhangDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Taofeek OwonikokoDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Manila GaddhDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Martha L ArellanoDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hanna J KhouryDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Fadlo R KhuriDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sumin KangDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Paul W DoetschDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sagar LonialDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Titus J BoggonDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Walter J CurranDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jing ChenDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: jchen@emory.edu.
Emory University · USFudan University · CNThe University of Texas Southwestern Medical Center · USNovartis (United States) · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Tyrosine Kinase Signaling in Cancer Cell MetabolismR01CA140515 · NCI · UNIVERSITY OF CHICAGO · PI Jing Chen · 2010 to 2026
$5.4M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human CancersR01CA174786 · NCI · UNIVERSITY OF CHICAGO · PI CHEN, JING · 2014 to 2024
$3.7M
Transcription-dependent and -independent signaling of RSK2 in cancer metastasisR01CA175316 · NCI · EMORY UNIVERSITY · PI KANG, SUMIN · 2014 to 2023
$3.5M
MR Investigation of IDH Mutation and Its Marker 2-HG in Brain Tumor PatientsR01CA169937 · NCI · EMORY UNIVERSITY · PI MAO, HUI · 2013 to 2017
$1.9M
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effectR01CA183594 · NCI · EMORY UNIVERSITY · PI CHEN, JING · 2014 to 2018
$1.6M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA140515NCI NIH HHS R01 CA169937NCI NIH HHS R01 CA174786NCI NIH HHS R01 CA175316NCI NIH HHS R01 CA183594NIGMS NIH HHS T32 GM008602
6 · The paper itself

Abstract

Mitochondrial acetyl-CoA acetyltransferase 1 (ACAT1) regulates pyruvate dehydrogenase complex (PDC) by acetylating pyruvate dehydrogenase (PDH) and PDH phosphatase. How ACAT1 is "hijacked" to contribute to the Warburg effect in human cancer remains unclear. We found that active, tetrameric ACAT1 is commonly upregulated in cells stimulated by EGF and in diverse human cancer cells, where ACAT1 tetramers, but not monomers, are phosphorylated and stabilized by enhanced Y407 phosphorylation. Moreover, we identified arecoline hydrobromide (AH) as a covalent ACAT1 inhibitor that binds to and disrupts only ACAT1 tetramers. The resultant AH-bound ACAT1 monomers cannot reform tetramers. Inhibition of tetrameric ACAT1 by abolishing Y407 phosphorylation or AH treatment results in decreased ACAT1 activity, leading to increased PDC flux and oxidative phosphorylation with attenuated cancer cell proliferation and tumor growth. These findings provide a mechanistic understanding of how oncogenic events signal through distinct acetyltransferases to regulate cancer metabolism and suggest ACAT1 as an anti-cancer target.

Indexed as

Acetyl-CoA C-AcetyltransferaseAnimalsCell Line, TumorCell ProliferationEpidermal Growth FactorGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansMiceMice, NudeMitochondriaNeoplasmsNIH 3T3 CellsOligopeptidesPhosphorylationProtein-Tyrosine KinasesACAT1 protein, humanAcetyl-CoA C-AcetyltransferaseEpidermal Growth FactorFGFR1 protein, humanFLAG peptideOligopeptidesProtein-Tyrosine KinasesPyruvate Dehydrogenase ComplexReceptor, Fibroblast Growth Factor, Type 1acetyl-CoA acetyltransferase 1arecoline hydrobromidecancer metabolismcancer therapymitochondriapyruvate dehydrogenase complextetramer formationtyrosine phosphorylationWarburg effect

Identifiers

PMID27867011
PMCPMC5135630
OpenAlexW2554694070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.